Radiosensitivity of connexin 43(CX43) on S24-GBMSCs based brain tumor in nude mice
Huang Lulu1, Liu Shengwen2, Zhang Mengxian1, Yu Shiying1, Qiu Hong1, Hu Guoqing1
1Department of Oncology, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China; 2Department of Neurosurgery, Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China
Abstract:Objective Toinvestigate the impact of connexin 43(CX43) on the connection of S24glioblastoma multiforme (S24-GBM) cellular network and to explore its role on radio-resistance. Methods Specific lentiviral vectors were used to knockout CX43 in S24-GBM stem cells (S24-GBMSCs). Alternatively, carbenoxolone (CBX) was used to block transmission of CX43. Subsequently, the animal subjects grafted with S24-GBMSCs were monitored under a multiphoton laser scanning microscope (MPLSM). Dynamic changes of tumor microtubes (TMs) and transmission of Ca2+ and SR101 in the cellular network were recorded. To study the radiosenstivity of S24-GBM before and after CX43 inhibition, MRI scanning of the brains was taken before and after radiation to assess the tumor sizes. Survival time of each subject was also recorded. Results In comparison with control group, knockout of CX43 in S24-GBMSCs led to shorter TMs, less TM connected cells, lower Ca2+ synchronicity and SR101 fluorescence, as well as decreased tumor sizes and prolonged survival time (all P<0.01), which were independent from radiation. However, CBX only demonstrated inhibition on the growth of tumors and the diffussion of Ca2+ and SR101, without affecting TMs formation. These above-mentioned alterations could be enhanced by the combination of gap43 knockout in S24-GBMSCs with blockage of CX43 by CBX (all P<0.05). Conclusion CX43 plays a critical role in the radioresistance of S24-GBM by influencing the formation of S24-GBM cellular network and the transmission of important signaling molecules including Ca2+ and SR101.
Huang Lulu,Liu Shengwen,Zhang Mengxian et al. Radiosensitivity of connexin 43(CX43) on S24-GBMSCs based brain tumor in nude mice[J]. Chinese Journal of Radiation Oncology, 2020, 29(5): 383-387.
[1] Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase Ⅲ study:5-year analysis of the EORTC-NCIC trial[J]. Lancet Oncol, 2009, 10(5):459-466. DOI:10.1016/S1470-2045(09)70025-7.
[2] Weller M, Cloughesy T, Perry JR, et al. Standards of care for treatment of recurrent glioblastoma—are we there yet?[J]. Neuro Oncol, 2013, 15(1):4-27. DOI:10.1093/neuonc/nos273.
[3] Shergalis A, Bankhead A 3rd, Luesakul U, et al. Current challenges and opportunities in treating glioblastoma[J]. Pharmacol Rev, 2018, 70(3):412-445. DOI:10.1124/pr.117.014944.
[4] Aasen T, Johnstone S, Vidal-Brime L, et al. Connexins:synthesis, post-translational modifications, and trafficking in health and disease[J]. Int J Mol Sci, 2018, 19(5):1296. DOI:10.3390/ijms19051296.
[5] Osswald M, Jung E, Sahm F, et al. Brain tumour cells interconnect to a functional and resistant network[J]. Nature, 2015, 528(7580):93-98. DOI:10.1038/nature16071.
[6] Weil S, Osswald M, Solecki G, et al. Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas[J]. Neuro Oncol, 2017, 19(10):1316-1326. DOI:10.1093/neuonc/nox070.
[7] McLachlan E, Shao Q, Wang HL, et al. Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis[J]. Cancer Res, 2006, 66(20):9886-9894. DOI:10.1158/0008-5472. CAN-05-4302.
[8] Lamiche C, Clarhaut J, Strale PO, et al. The gap junction protein Cx43 is involved in the bone-targeted metastatic behaviour of human prostate cancer cells[J]. Clin Exp Metast, 2012, 29(2):111-122. DOI:10.1007/s10585-011-9434-4.
[9] Aasen T, Sansano I, Montero MA, et al. Insight into the role and regulation of Gap junction genes in lung cancer and identification of nuclear CX43 as a putative biomarker of poor prognosis[J]. Cancers (Basel), 2019, 11(3). DOI:10.3390/cancers11030320.
[10] Wang J, Yang ZY, Guo YF, et al. Targeting different domains of gap junction protein to control malignant glioma[J]. Neuro Oncol, 2018, 20(7):885-896. DOI:10.1093/neuonc/nox207.
[11] Wang L, Peng Y, Peng J, et al. Tramadol attenuates the sensitivity of glioblastoma to temozolomide through the suppression of Cx43mediated gap junction intercellular communication[J]. Int J Oncol, 2018, 52(1):295-304. DOI:10.3892/ijo.2017.4188.
[12] Tabernero A, Medina JM, Giaume C. Glucose metabolism and proliferation in glia:role of astrocytic gap junctions[J]. J Neurochem, 2006, 99(4):1049-1061. DOI:10.1111/j.1471-4159.2006.04088.x.
[13] Huang RP, Fan Y, Hossain MZ, et al. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43(cx43)[J]. Cancer Res, 1998, 58(22):5089-5096.
[14] Klumpp L, Sezgin EC, Skardelly M, et al. KCa3.1 channels and glioblastoma:in vitro studies[J]. Curr Neuropharmacol, 2018, 16(5):627-635. DOI:10.2174/1570159X15666170808115821.
[15] Tombal B, Denmeade SR, Gillis JM, et al. A supramicromolar elevation of intracellular free calcium{[Ca (2+)](i)} is consistently required to induce the execution phase of apoptosis[J]. Cell Death Differ, 2002, 9(5):561-573. DOI:10.1038/sj.cdd.4400999.
[16] McFerrin MB, Turner KL, Cuddapah VA, et al. Differential role of IK and BK potassium channels as mediators of intrinsic and extrinsic apoptotic cell death[J]. Am J Physiol Cell Physiol, 2012, 303(10):C1070-1078. DOI:10.1152/ajpcell.00040.2012.
[17] Okolie O, Bago JR, Schmid RS, et al. Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model[J]. Neuro Oncol, 2016, 18(12):1622-1633. DOI:10.1093/neuonc/now117.
[18] Laird DW, Naus CC, Lampe PD. Snapshot:connexins and disease[J]. Cell, 2017, 170(6):1260-1260.e1. DOI:10.1016/j.cell.2017.08.034.